UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry

Thromb Res. 2021 Jan:197:16-19. doi: 10.1016/j.thromres.2020.10.021. Epub 2020 Oct 20.
No abstract available

Keywords: Factor Xa Inhibitors; Obesity; Rivaroxaban; Venous thromboembolism.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use
  • Factor Xa Inhibitors / therapeutic use
  • Humans
  • Obesity / complications
  • Obesity / drug therapy
  • Registries
  • Rivaroxaban* / therapeutic use
  • United Kingdom
  • Venous Thromboembolism* / drug therapy

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Rivaroxaban